ArticleCancers2026

Long-Term Outcomes of a Multidisciplinary Treatment Strategy Using Neoadjuvant Gemcitabine Plus S-1 Based on Anatomical Resectability Classification and Lymph Node Status in Patients with Perihilar Cholangiocarcinoma.

Naohisa Kuriyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.